May 4, 2026

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 10.60% Potential Upside

Bausch + Lomb Corporation (NYSE: BLCO), a venerable name in eye health solutions, is capturing the attention of investors with a notable potential upside of 10.60%. With a market capitalization..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Exploring a Promising 18.40% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is capturing the attention of investors with its robust market cap of $7.83 billion and a promising pipeline of genetic medicines aimed at addressing diseases..

Elanco Animal Health (ELAN) Stock Analysis: Impressive Revenue Growth and Strong Buy Ratings Propel Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN), with its $11.24 billion market cap, presents an intriguing opportunity for investors within the healthcare sector, particularly in the niche of drug manufacturers specializing..

TransMedics Group, Inc. (TMDX) Investor Outlook: A Healthcare Innovator with a 55.98% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX), a rising star in the healthcare sector, is drawing investor attention with its innovative approach to organ transplantation and an impressive potential upside of 55.98%...

Grifols, S.A. (GRFS) Valuation Insights: Unlocking a 34.87% Potential Upside in Healthcare Innovation

Grifols, S.A. (NASDAQ: GRFS), a Spanish healthcare giant specializing in plasma-derived medicines, stands at an intriguing crossroads for investors, especially as the stock currently trades at $8.23 with an enticing..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Exploring a 47.3% Potential Upside in Biotech Innovation

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, commands investor attention with a robust market capitalization of $7.87 billion. The company stands at the forefront of biopharmaceutical..

Bruker Corporation (BRKR) Investor Outlook: Exploring a 27% Potential Upside in the Healthcare Sector

Bruker Corporation (NASDAQ: BRKR), a prominent name in the healthcare sector, specializes in the development, manufacturing, and distribution of scientific instruments, as well as analytical and diagnostic solutions. With a..

Exelixis, Inc. (EXEL) Investor Outlook: Exploring a Promising 8.81% Upside Potential

Exelixis, Inc. (EXEL), a prominent player in the biotechnology sector, has captured investor attention with its focus on groundbreaking oncology therapies. Specializing in the discovery and development of treatments for..

Integer Holdings Corporation (ITGR): Analyst Consensus Highlights a 13% Potential Upside

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector specializing in medical devices, has drawn significant attention from investors with its solid growth potential and strategic positioning...

Regencell Bioscience Holdings L (RGC): Growth Potential in the Booming TCM Market

Investors intrigued by the burgeoning Traditional Chinese Medicine (TCM) sector should keep an eye on Regencell Bioscience Holdings L (NASDAQ: RGC), a promising player in the healthcare industry with a..

Sarepta Therapeutics (SRPT) Stock Analysis: Navigating the Biotech Terrain with a 1.36% Potential Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, offers a compelling yet complex investment narrative for those interested in the healthcare industry. With a focus on..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 43.75% Potential Upside with Promising Oncology Innovations

Nuvalent, Inc. (NASDAQ: NUVL), a burgeoning player in the biotechnology sector, has captured the attention of investors with a market capitalization of $7.82 billion. Specializing in the development of innovative..

The Cooper Companies, Inc. (COO) Stock Analysis: A Look at Its 46% Potential Upside

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, presents a compelling opportunity for investors with its current..

BrightSpring Health Services (BTSG) Stock Analysis: Strong Buy Ratings and 7.73% Potential Upside

BrightSpring Health Services, Inc. (BTSG) is making waves in the healthcare sector, specifically within the health information services industry. As a prominent player in delivering comprehensive pharmacy and provider services..

Humana Inc. (HUM) Stock Analysis: Navigating Healthcare Growth with a 2.94% Upside Potential

Humana Inc. (NYSE: HUM), a prominent player in the healthcare plans industry, is capturing investor attention with its robust revenue growth and a strategic focus on expanding its service offerings...

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a Promising 42% Upside Potential

Prestige Consumer Healthcare Inc. (PBH) stands out in the healthcare sector with a robust portfolio of over-the-counter (OTC) health and personal care products. Based in Tarrytown, New York, Prestige operates..

Doximity, Inc. (DOCS) Stock Analysis: Analyst Ratings Suggest 51% Potential Upside in Healthcare Tech

Doximity, Inc. (NYSE: DOCS), a prominent player in the healthcare technology sector, is capturing the attention of individual investors with an impressive potential upside of 51.21%, based on analyst ratings...

Smith & Nephew SNATS, Inc. (SNN) Investor Outlook: Navigating a 15.73% Potential Upside in the Medical Device Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector, particularly in the medical devices industry, is currently presenting a compelling opportunity for investors looking to..

Glaukos Corporation (GKOS) Stock Analysis: Healthcare Innovator with 7.75% Upside Potential

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector specializing in medical devices, has been capturing investor attention with its innovative approach to treating ophthalmic conditions. The company,..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Close Look at the Biotechnology Innovator’s Market Position and Potential

Soleno Therapeutics, Inc. (NASDAQ: SLNO) stands at the forefront of the biotechnology sector, focusing on the development of novel therapeutics for rare diseases. With a market capitalization of $2.73 billion,..

Search

Funds

May 4, 2026

Search

Funds

May 4, 2026

FTSE 100

Funds